The Federal Watchdog evaluated during the 2012-2014 funding and use of resources of the federal agencies that have responsibility for investigating regenerative medicine.

One of the reasons for which it is researching on this type of medicine is because many people die waiting for an organ transplant. In fact, the Argentine audit also assessed our country long ago, the drawbacks of the transplant system in Argentina. Therefore scientists are looking for ways to help restore organs "by using therapies to regenerate cells."

It notes that this medicine also called "tissue engineering" - serves in turn to try to "persons with limb loss and severe burns." It is working to "improve the restoration of bones and reduce the pain, bleeding and scars" and to "reduce the amount of skin that would have to be harvested for the treatment of a burn patient."

The US control body found that there are seven federal agencies investing 2.89 billion dollars in research in this treatment "to improve scientific knowledge" and to "move discoveries into practical applications."

Given the amount of public money spent in this area of health, it is necessary that these bodies make an exchange of information on the subject.

According to the audit, the agencies established mechanisms such as the "participation of regular meetings of an interagency working group", the "co-financing of research" and "Co-sponsored workshops."

However, some officials and agencies interested in the subject say that there is still a "variety of challenges in the progress of regenerative medicine" that the agencies themselves should face: "effective partnerships between federal and nonfederal stakeholders," "the hiring of specialized scientists to become civil servants" and "review and regulatory approval of the products."

Given this situation, the agencies claim they hired "postdoctoral fellows" and trained to "build the necessary mix of interdisciplinary skills for research in regenerative medicine."